Slide of the Month
The assessment of quality decision making in one of three settings. From Bujar M et al. Assessment of the ten quality decision-making practices; case studies with a pharmaceutical company, a regulatory and an HTA agency. DIA, 2018.
Where to meet us
- The Latin America Forum at the Regulatory Affairs Professionals Society (RAPS) Regulatory Convergence; Vancouver Convention Centre, Vancouver, BC; Wednesday, 3 October 2019, 10:30 am-12:00 pm (overall conference, 1-4 October, 2019) Dr Lawrence Liberti, speaker: “State of the Art Facilitated Regulatory Pathways: Global and Latin America Overview”
- Malaysia National Regulatory Conference (NRC) 2018; 2-4 October 2018; Selangor, Malaysia
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe 2018; 10-14 November 2018; Barcelona Spain
Our most recent publications
Mashaki Ceyhan E, Gürsöz H, Alkan A, Coşkun H, Koyuncu O, Walker S. The Turkish Medicines and Medical Devices Agency: Comparison of its registration process with Australia, Canada, Saudi Arabia, and Singapore. Front Pharmacol. 2018;9 DOI=10.3389/fphar.2018.
Walker S, McAuslane N, Bujar M, Connelly P, Liberti L. Quality decision-making practices: Their application and impact in the development, review and reimbursement of medicines. Netherlands: Off Page, 2017.